Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

Regeneron Pharmaceuticals · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
relapsed/refractory multiple myeloma (rrmm), cytokine release syndrome (crs), linvoseltamab, tocilizumab, bispecific antibodies, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 899585
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.